Mount Sinai advances prostate care with AI-powered therapy designed to preserve continence and sexual function The Mount Sinai Hospital is ranked ...

Ernie Strauss and Ronald Wakefield, who met through the patient navigation program of Northside Hospital, have built a ...

Ever woken up multiple times at night, groggy and frustrated, just to rush to the bathroom? You might blame your bladder, or ...

AxoGen (NASDAQ:AXGN) outlined its strategy to expand peripheral nerve repair adoption and improve profitability following the ...

Spanning governance, security, economics, science and artificial intelligence, The Africa Report profiles 10 academics ...

Profound is a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue.

A new article published in Nature Medicine has shown how a new AI model can be used to predict future disease risk, including ...

Hearing the words “you have cancer” is uniquely frightening and devastating, and those life-altering words are spoken to ...

Tierney says that if there’s one category oncology dietitians consistently encourage people to eat more of, it’s non-starchy ...

Dr Vishakha shares some blood tests that can help men monitor and maintain their optimal health, detect potential issues ...

Boehringer Ingelheim begins phase IIa trial of BI 765423, a novel monoclonal antibody targeting IL-11, in patients with idiopathic pulmonary fibrosis: Ingelheim, Germany Thursday, ...

-- BI 765423 has been developed to target IL-11, a key driver of fibrosis -- New study will investigate potential of BI 765423 to improve lung function for patients with idiopathic pulmonary fibrosis ...